• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整蛋白和定义的 CD8(+) 和 CD4(+) 肽与穿透肽靶标结合,靶向 MHC Ⅰ类和Ⅱ类抗原呈递途径。

Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.

机构信息

Immunology and Vaccine Laboratory, Centre for Immunology, Burnet Institute, Melbourne, Victoria, Australia.

出版信息

Immunol Cell Biol. 2011 Nov;89(8):904-13. doi: 10.1038/icb.2011.13. Epub 2011 Mar 8.

DOI:10.1038/icb.2011.13
PMID:21383765
Abstract

Cytoplasmic delivery and cross-presentation of proteins and peptides is necessary for processing and presentation of antigens for the generation of cytotoxic T cells. We previously described the use of the 16 amino acid peptide penetratin from the Drosophila Antennapedia homeodomain (penetratin, Antp) to transport cytotoxic T lymphocyte epitopes derived from ovalbumin (OVA) or the Mucin-1 tumor-associated antigen into cells. We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells). The induction of these responses was directly mediated by the penetratin peptide as linking a nonspecific 16-mer peptide to OVA or mixing did not induce CD8(+) or CD4(+) T-cell responses in vitro. Furthermore, interferon (IFN)-γ-secreting CD4(+) and CD8(+) T cells were induced which suppressed B16.OVA tumor growth in C57BL/6 mice. Tumor protection was mediated by a CD8(+) T-cell-dependent mechanism and did not require CD4(+) help to protect mice 7 days after a boost immunization. Alternatively, 40 days after a boost immunization, the presence of CD4(+) help enhanced antigen-specific IFN-γ-secreting CD8(+) T cells and tumor protection in mice challenged with B16.OVA. Long-term CD8 responses were equally enhanced by antigen-specific and universal CD4 help. In addition, immunization with AntpOVA significantly delayed growth of B16.OVA tumors in mice in a tumor therapy model.

摘要

细胞质内递呈蛋白和肽是加工和递呈抗原以产生细胞毒性 T 细胞所必需的。我们之前描述了利用果蝇触角同源域 16 个氨基酸肽 penetratin(penetratin,Antp)转导细胞毒性 T 淋巴细胞表位衍生自卵清蛋白(OVA)或黏蛋白 1 肿瘤相关抗原。我们现在发现,OVA 蛋白与 penetratin 共价结合并串联连接到体外 OVA 刺激的 T 细胞中的 CD4(+)和/或 CD8(+)T 细胞表位(B3Z T 细胞杂交瘤和 OT-I 和 OT-II T 细胞)。这些反应的诱导是由 penetratin 肽直接介导的,因为将非特异性 16 肽与 OVA 连接或混合不会在体外诱导 CD8(+)或 CD4(+)T 细胞反应。此外,诱导产生了 IFN-γ 分泌的 CD4(+)和 CD8(+)T 细胞,可抑制 C57BL/6 小鼠中的 B16.OVA 肿瘤生长。肿瘤保护是由 CD8(+)T 细胞依赖性机制介导的,在加强免疫后 7 天不需要 CD4(+)辅助来保护小鼠。或者,在加强免疫后 40 天,CD4(+)辅助的存在增强了针对抗原的 IFN-γ 分泌的 CD8(+)T 细胞和在受到 B16.OVA 挑战的小鼠中的肿瘤保护。针对抗原的和通用的 CD4 辅助均同等增强了长期 CD8 反应。此外,AntpOVA 免疫在肿瘤治疗模型中显著延迟了 B16.OVA 肿瘤的生长。

相似文献

1
Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.整蛋白和定义的 CD8(+) 和 CD4(+) 肽与穿透肽靶标结合,靶向 MHC Ⅰ类和Ⅱ类抗原呈递途径。
Immunol Cell Biol. 2011 Nov;89(8):904-13. doi: 10.1038/icb.2011.13. Epub 2011 Mar 8.
2
Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.在缺乏CD4+ T细胞辅助的情况下,古脂质体通过外源性胞质途径诱导对包裹的可溶性蛋白产生长期的CD8+ 细胞毒性T细胞反应。
J Immunol. 2000 Nov 1;165(9):5177-85. doi: 10.4049/jimmunol.165.9.5177.
3
The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.对吸入性可溶性蛋白质抗原的天然免疫反应涉及主要组织相容性复合体(MHC)I类限制的CD8 + T细胞介导但MHC II类限制的CD4 + T细胞依赖性免疫偏离,从而导致免疫球蛋白E产生的选择性抑制。
J Exp Med. 1993 Sep 1;178(3):889-99. doi: 10.1084/jem.178.3.889.
4
Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.编码泛主要组织相容性复合体II类肽类似物的脱氧核糖核酸(DNA)增强了抗原特异性细胞免疫,并对DNA疫苗免疫疗法引发的肿瘤生长产生抑制作用。
Cancer Res. 2003 Nov 15;63(22):7920-5.
5
Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.用慢病毒载体进行免疫可刺激CD4和CD8 T细胞对卵清蛋白转基因产生反应。
Mol Ther. 2006 Feb;13(2):310-9. doi: 10.1016/j.ymthe.2005.08.025. Epub 2005 Nov 4.
6
Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.1型辅助性T细胞诱导肽增强CD8 + 细胞毒性T细胞反应及抗肿瘤抗性
Immunology. 2006 Jan;117(1):47-58. doi: 10.1111/j.1365-2567.2005.02262.x.
7
Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.活化的CD4+辅助性T细胞直接刺激野生型和MHC II基因敲除的C57BL/6小鼠以及表达胰岛β细胞卵清蛋白抗原的转基因RIP-mOVA小鼠体内的CD8+细胞毒性T淋巴细胞反应,从而导致糖尿病。
Autoimmunity. 2008 Nov;41(7):501-11. doi: 10.1080/08916930802069256.
8
Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.穿膜肽介导的疫苗递送:树突状细胞的抗原呈递机制
Immunol Res. 2016 Aug;64(4):887-900. doi: 10.1007/s12026-016-8799-5.
9
Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.细胞毒性T细胞对DNA疫苗接种的反应:依赖于通过II类主要组织相容性复合体进行的抗原呈递。
J Immunol. 1998 Dec 15;161(12):6532-6.
10
Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity.聚精氨酸介导的蛋白质递送至树突状细胞可更有效地将抗原呈递至MHC I类和II类分子上,并引发更强的抗肿瘤免疫反应。
J Invest Dermatol. 2006 Aug;126(8):1804-12. doi: 10.1038/sj.jid.5700335. Epub 2006 Apr 27.

引用本文的文献

1
Advances and prospects of cell-penetrating peptides in tumor immunotherapy.细胞穿透肽在肿瘤免疫治疗中的研究进展与展望
Sci Rep. 2025 Jan 27;15(1):3392. doi: 10.1038/s41598-025-86130-8.
2
Immunoinformatics Approach to Design a Chimeric CD70-Peptide Vaccine against Renal Cell Carcinoma.设计针对肾细胞癌的嵌合型CD70-肽疫苗的免疫信息学方法
J Immunol Res. 2024 Jan 27;2024:2875635. doi: 10.1155/2024/2875635. eCollection 2024.
3
Peptide-Drug Conjugates: A New Hope for Cancer Management.肽药物偶联物:癌症管理的新希望。
Molecules. 2022 Oct 25;27(21):7232. doi: 10.3390/molecules27217232.
4
Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity.细胞穿透肽增强了肽疫苗在淋巴结中的积累和持久性,从而增强了免疫原性。
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2204078119. doi: 10.1073/pnas.2204078119. Epub 2022 Aug 1.
5
TAT for Enzyme/Protein Delivery to Restore or Destroy Cell Activity in Human Diseases.用于酶/蛋白质递送以恢复或破坏人类疾病中细胞活性的转导激活子(TAT)
Life (Basel). 2021 Sep 6;11(9):924. doi: 10.3390/life11090924.
6
Cell-penetrating Peptides: Efficient Vectors for Vaccine Delivery.细胞穿透肽:疫苗传递的有效载体。
Curr Drug Deliv. 2019;16(5):430-443. doi: 10.2174/1567201816666190123120915.
7
Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope.三部分细胞穿透肽的免疫原性,该肽包含一个 MUC1 可变数目的串联重复(VNTR)和一个 T 辅助表位。
Molecules. 2018 Sep 2;23(9):2233. doi: 10.3390/molecules23092233.
8
Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.基于细胞穿透肽的癌症疫苗功效的机制见解。
Cell Mol Life Sci. 2018 Aug;75(16):2887-2896. doi: 10.1007/s00018-018-2785-0. Epub 2018 Mar 5.
9
Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.穿膜肽介导的疫苗递送:树突状细胞的抗原呈递机制
Immunol Res. 2016 Aug;64(4):887-900. doi: 10.1007/s12026-016-8799-5.
10
Use of Cell-Penetrating Peptides in Dendritic Cell-Based Vaccination.细胞穿透肽在基于树突状细胞的疫苗接种中的应用。
Immune Netw. 2016 Feb;16(1):33-43. doi: 10.4110/in.2016.16.1.33. Epub 2016 Feb 25.